Controlled ex-vivo effect of sulfinpyrazone on platelet function of myocardial infarction patients.
D000328:Adult; D000704:Analysis of Variance; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000517:prevention & control; D010919:Placebos; D010974:Platelet Aggregation / Q000187:drug effects; D010978:Platelet Factor 4 / Q000378:metabolism; D013442:Sulfinpyrazone / Q000008:administration & dosage / Q000627:therapeutic use*
D010919:Placebos; D010978:Platelet Factor 4; D013442:Sulfinpyrazone